Edwards Lifesciences Corp Stock Price on November 25, 2024
| EW Stock | USD 71.35 0.72 1.00% |
Below is the normalized historical share price chart for Edwards Lifesciences Corp extending back to March 27, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edwards Lifesciences stands at 71.35, as last reported on the 30th of November, with the highest price reaching 71.71 and the lowest price hitting 70.23 during the day.
If you're considering investing in Edwards Stock, it is important to understand the factors that can impact its price. At this stage we consider Edwards Stock to be very steady. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.0452, which denotes the company had a 0.0452% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please confirm Edwards Lifesciences' Downside Deviation of 1.5, coefficient of variation of 2229.89, and Mean Deviation of 1.17 to check if the risk estimate we provide is consistent with the expected return of 0.071%.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). . At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Edwards Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of March 2000 | 200 Day MA 79.4129 | 50 Day MA 67.9142 | Beta 1.12 |
Edwards |
Sharpe Ratio = 0.0452
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | EW | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.57 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Price Book 4.453 | Enterprise Value Ebitda 21.9982 | Price Sales 6.664 | Shares Float 583.8 M | Wall Street Target Price 76.605 |
Edwards Lifesciences Main Headline on 25th of November 2024
Glancy Prongay Murray LLP Reminds Investors of Looming Deadl... by gurufocus.com
LOS ANGELES, Nov. 25, 2024 -- Glancy Prongay Murray LLP reminds investors of the upcoming December 13, 2024 deadline to file a
Edwards Lifesciences Valuation on November 25, 2024
It is possible to determine the worth of Edwards Lifesciences on a given historical date. On November 25, 2024 Edwards was worth 71.0 at the beginning of the trading date compared to the closed value of 71.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Edwards Lifesciences stock. Still, in general, we apply an absolute valuation method to find Edwards Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Edwards Lifesciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Edwards Lifesciences' related companies.
| Open | High | Low | Close | Volume | |
| 70.31 | 71.00 | 69.96 | 70.48 | 2,711,629 | |
11/25/2024 | 71.00 | 71.41 | 70.15 | 71.27 | 6,645,296 |
| 71.50 | 72.44 | 70.76 | 71.55 | 4,643,382 |
| Backtest Edwards Lifesciences | | | Edwards Lifesciences History | | | Edwards Lifesciences Valuation | Previous | Next |
Edwards Lifesciences Trading Date Momentum on November 25, 2024
| On November 26 2024 Edwards Lifesciences Corp was traded for 71.55 at the closing time. The highest price during the trading period was 72.44 and the lowest recorded bid was listed for 70.76 . The volume for the day was 4.6 M. This history from November 26, 2024 contributed to the next trading day price increase. The overall trading delta to the next closing price was 0.39% . The overall trading delta to the current price is 0.42% . |
Edwards Lifesciences Corp Fundamentals Correlations and Trends
By evaluating Edwards Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Edwards financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Edwards Lifesciences Stock history
Edwards Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edwards is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edwards Lifesciences Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edwards Lifesciences stock prices may prove useful in developing a viable investing in Edwards Lifesciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 609.4 M | 550.8 M | |
| Net Income Applicable To Common Shares | 1.8 B | 1.8 B |
Edwards Lifesciences Quarterly Net Working Capital |
|
Edwards Lifesciences Stock Technical Analysis
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Edwards Lifesciences Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Edwards Lifesciences Corp cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Edwards Lifesciences November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Edwards Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edwards Lifesciences shares will generate the highest return on investment. By undertsting and applying Edwards Lifesciences stock market strength indicators, traders can identify Edwards Lifesciences Corp entry and exit signals to maximize returns
Edwards Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edwards Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Edwards Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edwards to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0394 | |||
| Jensen Alpha | 0.0354 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.3075 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.